• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

What We're Reading: Immigrants Drop Medi-Cal; Employer-Backed Insurance; and Anthem-Cigna Drama

Article

Some Immigrants in California Cancel Health Insurance

In California, legal immigrants are not enrolling in Medi-Cal or are canceling coverage in the wake of the Trump administration’s approach to immigrants, reported California Healthline. Legal immigrants are concerned that enrolling in Medi-Cal may put family members who do not have legal status in danger of being deported. In addition, some worry that they may be penalized for using public benefits even though they are legally eligible for these benefits. However, immigration experts note that canceling coverage may not help—their names are already in the system.

ACA Repeal and Replace May Affect Employer-Sponsored Insurance Tax Breaks

As Republicans work on a plan to replace the Affordable Care Act (ACA), they need to find a way to offset the costs of providing tax credits for individuals. One potential plan is to cap how much of employer health benefits can be protected from taxes. The health insurance benefit that employees receive from employers currently isn't taxed, but the new plan could limit how much is tax free. Health plans that exceed the limit on the value of these benefits would be subject to income tax on the amount the difference. Democrats worry that this strategy could mean employers offer less generous plans.

Cigna and Anthem’s Merger Saga Continues

A judge has temporarily blocked Cigna’s attempt to immediately terminate its proposed merger from Anthem, The Wall Street Journal reported. After a judge blocked the merger between Anthem and Cigna, Cigna sought to terminate the merger, plus sued Anthem for $13 billion in damages. Anthem filed its own lawsuit to prevent Cigna from immediately ending the deal, and is trying to appeal the ruling that blocked the merger. The merger has been contentious between the 2 companies, with both accusing the other of violating the deal.

Related Videos
Will Shapiro
Patrick Vermersch, MD, PhD
Pat Van Burkleo
Video 1 - "Diagnosing and Understanding the Pathogenesis of Bronchiectasis"
Video 4 - "Challenges in Autoantibody Screening for Type 1 Diabetes"
Jeff Stark, MD, vice president, head of medical immunology, UCB
Video 7 - "Prior Authorization and Access to Targeted Treatment for Ph+ ALL Patients"
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.